{"disease":{"id":"lupus-erythematosus-systemic","name":"lupus erythematosus systemic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04402086","title":"Rheumatology Patient Registry and Biorepository","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT03142412","title":"Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"DxTerity Diagnostics","has_results":false},{"nct_id":"NCT05879419","title":"Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2005,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT05141201","title":"SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1620,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07000916","title":"Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Université Catholique de Louvain","has_results":false},{"nct_id":"NCT07123220","title":"Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus","phase":"","overall_status":"COMPLETED","enrollment_count":884,"lead_sponsor_name":"Investigación en Hemofilia y Fisioterapia","has_results":false},{"nct_id":"NCT02988661","title":"Women Empowered to Live With Lupus Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":699,"lead_sponsor_name":"Emory University","has_results":true},{"nct_id":"NCT07438496","title":"A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT04961567","title":"A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":562,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT04895241","title":"A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":548,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT03517722","title":"A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":516,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT07515638","title":"Immun4Cure Cohort of Autoimmune Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT07087912","title":"Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":477,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT05672576","title":"A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":451,"lead_sponsor_name":"Viatris Innovation GmbH","has_results":false},{"nct_id":"NCT05763225","title":"Validation of Patient E-tool to Measure Systemic Lupus Activity","phase":"","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"Association Francaise du Lupus et Autres Maladies Auto-immunes (AFL+)","has_results":false},{"nct_id":"NCT06593041","title":"ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT05648500","title":"A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":420,"lead_sponsor_name":"Viatris Innovation GmbH","has_results":false},{"nct_id":"NCT03248518","title":"Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":368,"lead_sponsor_name":"University of Aberdeen","has_results":false},{"nct_id":"NCT05961267","title":"Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism","phase":"","overall_status":"COMPLETED","enrollment_count":318,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT03816345","title":"Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04449653","title":"Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Progentec Diagnostics, Inc.","has_results":false},{"nct_id":"NCT04361734","title":"The Role of Lipids in Immune Cell Function in SLE Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT05590390","title":"Osteoporosis and Fragility Fractures Among SLE Patients. (FRAIL Trial)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT06887517","title":"Chinese Rheumatism Biobank(CRB)","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Chinese SLE Treatment And Research Group","has_results":false},{"nct_id":"NCT03161483","title":"A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":289,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT06880653","title":"Dose Response of Exercise for Arthritis Management","phase":"NA","overall_status":"RECRUITING","enrollment_count":285,"lead_sponsor_name":"University of South Carolina","has_results":false},{"nct_id":"NCT05869955","title":"A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":270,"lead_sponsor_name":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","has_results":false},{"nct_id":"NCT05289544","title":"Phone-Based Based Walk With Ease Program for Adults With Arthritis","phase":"NA","overall_status":"COMPLETED","enrollment_count":267,"lead_sponsor_name":"University of South Carolina","has_results":true},{"nct_id":"NCT00137969","title":"A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":262,"lead_sponsor_name":"Genentech, Inc.","has_results":true},{"nct_id":"NCT05000216","title":"COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":258,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT02070978","title":"Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":253,"lead_sponsor_name":"EMD Serono","has_results":true},{"nct_id":"NCT03144063","title":"Improving the Assessment of SLE Disease Activity","phase":"","overall_status":"COMPLETED","enrollment_count":247,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT07000903","title":"Occupational and Environmental Causes of Autoimmune Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":247,"lead_sponsor_name":"Université Catholique de Louvain","has_results":false},{"nct_id":"NCT00582465","title":"Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus","phase":"","overall_status":"COMPLETED","enrollment_count":243,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04736953","title":"Sirolimus Treatment Of Patients With SLE","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":220,"lead_sponsor_name":"State University of New York - Upstate Medical University","has_results":false},{"nct_id":"NCT01753193","title":"An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":218,"lead_sponsor_name":"MedImmune LLC","has_results":true},{"nct_id":"NCT07330245","title":"Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.","phase":"","overall_status":"RECRUITING","enrollment_count":218,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04925934","title":"Study of VIB7734 for the Treatment of Moderate to Severely Active SLE","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":214,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03575156","title":"Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":208,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06888973","title":"Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"National Institute of Blood and Marrow Transplant (NIBMT), Pakistan","has_results":false},{"nct_id":"NCT05845593","title":"Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE)","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Ampel BioSolutions, LLC","has_results":false},{"nct_id":"NCT06087523","title":"Pulmonary Disease Among Patients With Systemic Lupus Erythematosus","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Odense University Hospital","has_results":false},{"nct_id":"NCT07251179","title":"Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT02653287","title":"Lupus Intervention for Fatigue Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT06544343","title":"Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":190,"lead_sponsor_name":"University Of Perugia","has_results":false},{"nct_id":"NCT05899907","title":"Efficacy and Safety of Telitacicept in Early SLE","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT05636670","title":"Assessment of Cognitive Function and Gut Microbiota Analysis in Real World Patients With Lupus Cerebrovascular Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06581198","title":"A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":179,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT02953821","title":"Acthar Gel for Active Systemic Lupus Erythematosus (SLE)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"Mallinckrodt","has_results":true},{"nct_id":"NCT04266860","title":"Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":166,"lead_sponsor_name":"Qure Healthcare, LLC","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}